Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO)
- Arbeitsgruppe Angewandte Mathematik/Numerik
- University of Kiel
- Paracelsus Medical University
- Friedrich Schiller University Jena
- St. Marien-Krankenhaus Siegen
- University of Düsseldorf
- Vivantes Klinikum Neukolln
- University of Erlangen–Nuremberg
- formerly St.-Vincentius-Hospital Karlsruhe
- St. Clara Hospital
- Marien Hospital Stuttgart
- University of Tubingen
8
Link opens in a new tab
Citations
(Scopus)